Current Research in Translational Medicine

Papers
(The median citation count of Current Research in Translational Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Anti-oxidant, antibacterial, anti-biofilm, and anti-quorum sensing activities of four essential oils against multidrug-resistant bacterial clinical isolates49
Machine learning and artificial intelligence in the service of medicine: Necessity or potentiality?45
Thoughts on cartilage tissue engineering: A 21st century perspective35
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges27
Mechanistic insights into the role of pyroptosis in rheumatoid arthritis26
A common TMPRSS2 variant has a protective effect against severe COVID-1926
Role of Nrf2 in rheumatoid arthritis25
Role of HDAC inhibitors in diabetes mellitus23
Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials20
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine19
Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli19
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation17
Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy15
A review of potential treatments to date in COVID-19 patients according to the stage of the disease15
Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy14
Heparin beyond anti-coagulation14
Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases14
Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease14
Role and mechanism of LAIR-1 in the development of autoimmune diseases, tumors, and malaria: A review13
COVID-19 paraclinical diagnostic tools: Updates and future trends12
Clinical prognosis evaluation of COVID-19 patients: An interpretable hybrid machine learning approach10
Cell therapy for prenatal repair of myelomeningocele: A systematic review10
Astaxanthin attenuates acute cerebral infarction via Nrf-2/HO-1 pathway in rats10
European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party9
Preclinical study of a DNA vaccine targeting SARS-CoV-28
IFNG-AS1 and MAF4 long non-coding RNAs are upregulated in acute leukemia patients who underwent bone marrow transplantation8
In utero treatment of myelomeningocele with allogenic umbilical cord-derived mesenchymal stromal cells in an ovine model7
CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review7
Clinical determinants of relapse following CAR-T therapy for hematologic malignancies: Coupling active strategies to overcome therapeutic limitations7
Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial7
Biological responses to COVID-19: Insights from physiological and blood biomarker profiles7
Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease6
Identification of serum exosomal miR-98–5p, miR-183–5p, miR-323–3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms6
Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?6
In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens6
Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin6
Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia6
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection6
The use of intrathecal chemotherapy and dexamethasone for secondary prevention of blinatumomab-related neurotoxicity6
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia6
Comparison of mouse, rat and rabbit models for adipose - Derived stem cells (ASC) research5
Understanding the hematopoietic microenvironment in chronic myeloid leukemia: A concise review5
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans5
Exosomal miR-195 in hUC-MSCs alleviates hypoxia-induced damage of trophoblast cells through tissue factor pathway inhibitor 24
Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?4
The influence of DNMT3A and DNMT3B gene polymorphisms on acute myeloid leukemia risk in a Moroccan population4
PHF19 inhibition as a therapeutic target in multiple myeloma4
Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death4
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease4
Cryopreserved allogeneic mesenchymal stem cells enhance wound repair in full thickness skin wound model and cattle clinical teat injuries4
Expression and survival analysis of the STAT gene family in diffuse gliomas using integrated bioinformatics4
A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER24
Hydroxychloroquine in Covid-19: Does the end justify the means?3
The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing3
Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients 3
Optimal pre-emptive cytomegalovirus therapy threshold in a patient population with high prevalence of seropositive status3
Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria3
Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplant3
APOE ε4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain3
Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children3
Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis3
Advances in adoptive T-cell therapy for metastatic melanoma3
Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: A case report3
HLA and PF4 antibody production after adenoviral vector SARS-CoV-2 vaccination3
Gene signatures and prognostic values of m6A-related genes in multiple myeloma3
Preclinical-to-clinical innovations in stem cell therapies for liver regeneration3
A preclinical randomized controlled study of ischemia treated with Ginkgo biloba extracts: Are complex components beneficial for treating acute stroke?3
A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma3
Intrathecal methotrexate induced myelopathy, rare yet serious complication: A case report and review of the literature3
Are we there yet? cellular therapies for cutaneous T cell lymphoma2
Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML.2
Modifying gap junction communication in cancer therapy2
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set2
Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairment2
Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis2
Genetic polymorphisms and risk of MALT lymphoma in Greek population2
CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis2
Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy2
Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia✰,✰✰2
Improved biological performance of human cartilage-derived progenitors in platelet lysate xenofree media in comparison to fetal bovine serum media2
A common glomerular transcriptomic signature distinguishes diabetic kidney disease from other kidney diseases in humans and mice2
Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient2
Pectins from various sources inhibit galectin-3-related cardiac fibrosis2
In vitro blood brain barrier models: Molecular aspects and therapeutic strategies in glioma management1
Actinomycosis in a mandibular necro-osteolytic lesion in a patient with multiple myeloma treated with bisphosphonates1
The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study1
AML-derived extracellular vesicles negatively regulate stem cell pool size: A step toward bone marrow failure1
Altered platelet functions during treatment with apremilast for psoriatic arthritis: A case report1
FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia1
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience1
Clinical features and functions of a novel Lpl mutation C.986A>C (p.Y329S) in patient with hypertriglyceridemia1
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice1
Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients1
Utility of 18F-FDG PET/CT in medical care of a promyelocytic sarcoma1
Scaling up human mesenchymal stem cell manufacturing using bioreactors for clinical uses1
Lipidomics: An excellent tool for chronic disease detection1
COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease1
Genetic diversity and expression profile of Plasmodium falciparum Pf34 gene supports its immunogenicity1
A simple score (Biovid-19) based on biological parameters predicts transfer to intensive care units and death in COVID-19 patients1
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)1
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms’1
Antibodies to calnexin and mutated calreticulin are common in human sera1
Regulatory factors involved in Th17/Treg cell balance of immune thrombocytopenia1
0.024489164352417